The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2820-2827

  Nerpin, Elisabet ^a,b   Ingelsson, Erik ^a,c   Risérus, Ulf ^d   Sundström, Johan ^a   Larsson, Anders ^a   Jobs, Elisabeth ^a,b   Jobs, Magnus ^a,b   Hallan, Stein ^e   Zethelius, Björn ^a   Berglund, Lars ^a   Basu, Samar ^d   Ärnlöv, Johan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b DALARNA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

cardiovascular diseases; epidemiology; kidney; prognosis; risk factors

Indexed keywords

CYSTATIN C;

AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE;

AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; CYSTATIN C; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 80053177139     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq848     Document Type: Article

References (45)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J KidneyDis 2002; 39: S1-S266
2. Connolly JO, Woolfson RG. A critique of clinical guidelines for detection of individuals with chronic kidney disease. Nephron Clin Pract 2009; 111: c69-c73
3. Rifkin DE, Katz R, Chonchol M et al. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 2010; 25: 1560-1567
4. Foster MC, Hwang SJ, Larson MG et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007; 167: 1386-1392 (Pubitemid 47052437)
5. Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med 2007; 167: 2490-2496 (Pubitemid 350254909)
6. Hermans MM, Henry R, Dekker JM et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007; 18: 1942-1952 (Pubitemid 46870332)
7. Astor BC, Hallan SI, Miller ER 3rd et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 2: 2
8. Brantsma AH, Bakker SJ, de Zeeuw D et al. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006; 17: 331-335
9. CirilloM, LantiMP,Menotti A et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008; 168: 617-624 (Pubitemid 351471667)
10. Chronic Kidney Disease Prognosis C, Matsushita K, van der VeldeM et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
11. Byberg L, Zethelius B, McKeigue PM et al. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia 2001; 44: 2134-2139 (Pubitemid 34015465)
12. Zethelius B, Berglund L, Sundstrom J et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358: 2107-2116 (Pubitemid 351679597)
13. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254 (Pubitemid 46768608)
14. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
15. Larsson A, Malm J, Grubb A et al. Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 2004; 64: 25-30 (Pubitemid 38283206)
16. Merlo J, Lindblad U, Pessah-Rasmussen H et al. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 2000; 16: 235-243 (Pubitemid 30351427)
17. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004; 23: 2109-2123 (Pubitemid 38968032)
18. Antolini L, Nam B-H, D'Agostino RB. Inference on correlated discrimination mesures in survival analysis: a non parametric apprach. Statist Theory Methods 2004; 33: 2117-2135
19. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-12 (Pubitemid 351193639)
20. Soveri I, Arnlov J, Berglund L et al. Kidney function and discrimination of cardiovascular risk in middle-aged men. J Intern Med 2009; 266: 406-413
21. Gronnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal 1996; 2: 315-328 (Pubitemid 126415889)
22. Andersson T, Alfredsson L, Kallberg H et al. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579 (Pubitemid 41126030)
23. Hlatky MA, Greenland P, Arnett DK et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119: 2408-2416
24. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456 (Pubitemid 28516069)
25. Comper WD, Russo LM. The glomerular filter: an imperfect barrier is required for perfect renal function. Curr Opin Nephrol Hypertens 2009; 18: 336-342
26. Hermans MM, Henry RM, Dekker JM et al. Albuminuria, but not estimated glomerular filtration rate, is associated with maladaptive arterial remodeling: the Hoorn Study. J Hypertens 2008; 26: 791-797 (Pubitemid 351354928)
27. Russo LM, Comper WD, Osicka TM. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int Suppl 2004: S67-S68 (Pubitemid 43361436)
28. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42: 1050-1065 (Pubitemid 37413751)
29. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003 (Pubitemid 36712275)
30. Kannel WB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002; 11: 101-107 (Pubitemid 34614597)
31. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
32. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
33. Ruggenenti P, Perna A, Gherardi G et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359-364 (Pubitemid 29355751)
34. Agodoa LY, Appel L, Bakris GL et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-2728 (Pubitemid 32525368)
35. Sandhu S, Wiebe N, Fried LF et al. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006; 17: 2006-2016 (Pubitemid 44036185)
36. Shepherd J, Kastelein JJ, Bittner V et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol 2007; 2: 1131-1139
37. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393 (Pubitemid 36159355)
38. Ibsen H, Olsen MH, Wachtell K et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 2006; 29: 595-600 (Pubitemid 44115360)
39. de Zeeuw D, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-927 (Pubitemid 39128617)
40. Ibsen H, Olsen MH, Wachtell K et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 2005; 45: 198-202 (Pubitemid 40179960)
41. Rossing P, Hommel E, Smidt UM et al. Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney Int Suppl 1994; 45: S145-S149
42. Rossing P, Hommel E, Smidt UM et al. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 1994; 37: 511-516 (Pubitemid 24133655)
43. Lea J, Greene T, Hebert L et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med 2005; 165: 947-953 (Pubitemid 40563243)
44. Viktorsdottir O, Palsson R, Andresdottir MB et al. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 2005; 20: 1799-1807 (Pubitemid 41222591)
45. Tillin T, Forouhi N, McKeigue P et al. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study. J Am Soc Nephrol 2005; 16: 3702-3710 (Pubitemid 46211292)